Literature DB >> 29119051

USP51 promotes deubiquitination and stabilization of ZEB1.

Zhicheng Zhou1, Peijing Zhang1, Xiaoyu Hu1, Jongchan Kim1, Fan Yao1, Zhenna Xiao1,2, Liyong Zeng1, Liang Chang1, Yutong Sun3, Li Ma1,2.   

Abstract

ZEB1 is a transcription factor that induces epithelial-mesenchymal transition, tumor metastasis, and therapy resistance. ZEB1 protein is subject to ubiquitination and degradation, but the mechanism by which ZEB1 is stabilized in cells remains unclear. By screening a human deubiquitinase library, we identified USP51 as a deubiquitinase that binds, deubiquitinates, and stabilizes ZEB1. Depletion of USP51 in mesenchymal-like breast cancer cells led to downregulation of ZEB1 protein and mesenchymal markers, upregulation of E-cadherin, and inhibition of cell invasion. Conversely, overexpression of USP51 in epithelial cells resulted in upregulation of ZEB1 and mesenchymal markers. In addition, USP51 is able to regulate the expression of ZEB1 target genes. Importantly, USP51 is overexpressed in breast cancer patients and correlates with poor survival. Taken together, our findings suggest that USP51 is a ZEB1 deubiquitinase that may serve as an alternative pathway for targeting the cancer-promoting transcriptional factor ZEB1.

Entities:  

Keywords:  USP51; ZEB1; deubiquitinase

Year:  2017        PMID: 29119051      PMCID: PMC5665849     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  41 in total

Review 1.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.

Authors:  A Singh; J Settleman
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

Review 2.  Loss of tight junction barrier function and its role in cancer metastasis.

Authors:  Tracey A Martin; Wen G Jiang
Journal:  Biochim Biophys Acta       Date:  2008-11-14

Review 3.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

Authors:  Jing Yang; Robert A Weinberg
Journal:  Dev Cell       Date:  2008-06       Impact factor: 12.270

Review 4.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

Review 5.  Deubiquitinases in cancer: new functions and therapeutic options.

Authors:  J M Fraile; V Quesada; D Rodríguez; J M P Freije; C López-Otín
Journal:  Oncogene       Date:  2011-09-26       Impact factor: 9.867

6.  Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway.

Authors:  Spencer C Wei; Laurent Fattet; Jeff H Tsai; Yurong Guo; Vincent H Pai; Hannah E Majeski; Albert C Chen; Robert L Sah; Susan S Taylor; Adam J Engler; Jing Yang
Journal:  Nat Cell Biol       Date:  2015-04-20       Impact factor: 28.824

7.  The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer.

Authors:  Anna Chen; Christina S F Wong; Mira C P Liu; Colin M House; Jaclyn Sceneay; David D Bowtell; Erik W Thompson; Andreas Möller
Journal:  Oncotarget       Date:  2015-01-20

8.  A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.

Authors:  Ulrike Burk; Jörg Schubert; Ulrich Wellner; Otto Schmalhofer; Elizabeth Vincan; Simone Spaderna; Thomas Brabletz
Journal:  EMBO Rep       Date:  2008-05-16       Impact factor: 8.807

9.  ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis.

Authors:  D H Peng; C Ungewiss; P Tong; L A Byers; J Wang; J R Canales; P A Villalobos; N Uraoka; B Mino; C Behrens; I I Wistuba; R I Han; C A Wanna; M Fahrenholtz; K J Grande-Allen; C J Creighton; D L Gibbons
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

10.  The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.

Authors:  K Aigner; B Dampier; L Descovich; M Mikula; A Sultan; M Schreiber; W Mikulits; T Brabletz; D Strand; P Obrist; W Sommergruber; N Schweifer; A Wernitznig; H Beug; R Foisner; A Eger
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

View more
  31 in total

1.  Visfatin is involved in the cisplatin resistance of osteosarcoma cells via upregulation of Snail and Zeb1.

Authors:  Dexing Wang; Guowei Qian; Jin Wang; Tian Wang; Lian Zhang; Ping Yang; Feng Lin
Journal:  Cancer Biol Ther       Date:  2019-04-12       Impact factor: 4.742

2.  CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism.

Authors:  Zhen Zhang; Jianjun Li; Yang Ou; Guang Yang; Kaiyuan Deng; Qiong Wang; Zhaoyang Wang; Wenhao Wang; Quansheng Zhang; Hang Wang; Wei Sun; Peiqing Sun; Shuang Yang
Journal:  Signal Transduct Target Ther       Date:  2020-03-11

3.  USP37 is a SNAI1 deubiquitinase.

Authors:  Zhenna Xiao; Liang Chang; Jongchan Kim; Peijing Zhang; Qinglei Hang; Shannon Yap; Youming Guo; Zhicheng Zhou; Liyong Zeng; Xiaoyu Hu; Ashley Siverly; Yutong Sun; Li Ma
Journal:  Am J Cancer Res       Date:  2019-12-01       Impact factor: 6.166

4.  Ubiquitin-specific peptidase 2a (USP2a) deubiquitinates and stabilizes β-catenin.

Authors:  Jongchan Kim; Fatemeh Alavi Naini; Yutong Sun; Li Ma
Journal:  Am J Cancer Res       Date:  2018-09-01       Impact factor: 6.166

5.  Promotor methylation status of MAPK4 is a novel epigenetic biomarker for prognosis of recurrence in patients with thymic epithelial tumors.

Authors:  Wei Guan; Songlin Li; Zhimin Zhang; He Xiao; Juan He; Jian Li; Xuan He; Jia Luo; Yun Liu; Lin Lei; Jungang Ma; Lizhao Chen; Chuan Chen
Journal:  Thorac Cancer       Date:  2022-09-08       Impact factor: 3.223

Review 6.  SAGA-Dependent Histone H2Bub1 Deubiquitination Is Essential for Cellular Ubiquitin Balance during Embryonic Development.

Authors:  Farrah El-Saafin; Didier Devys; Steven A Johnsen; Stéphane D Vincent; László Tora
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

7.  USP11 Enhances TGFβ-Induced Epithelial-Mesenchymal Plasticity and Human Breast Cancer Metastasis.

Authors:  Daniel A Garcia; Christina Baek; M Valeria Estrada; Tiffani Tysl; Eric J Bennett; Jing Yang; John T Chang
Journal:  Mol Cancer Res       Date:  2018-05-03       Impact factor: 5.852

8.  Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation.

Authors:  Sarmad Al-Marsoummi; Emilie Vomhof-DeKrey; Marc D Basson
Journal:  Cell Physiol Biochem       Date:  2019

Review 9.  Non-redundant functions of EMT transcription factors.

Authors:  Marc P Stemmler; Rebecca L Eccles; Simone Brabletz; Thomas Brabletz
Journal:  Nat Cell Biol       Date:  2019-01-02       Impact factor: 28.824

10.  Non-canonical function of DGCR8 in DNA double-strand break repair signaling and tumor radioresistance.

Authors:  Qinglei Hang; Liyong Zeng; Li Wang; Litong Nie; Fan Yao; Hongqi Teng; Yalan Deng; Shannon Yap; Yutong Sun; Steven J Frank; Junjie Chen; Li Ma
Journal:  Nat Commun       Date:  2021-06-29       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.